785 research outputs found
Role of dopamine in dorsal medial prefrontal cortex in yohimbine-induced reinstatement of food seeking in rats
In humans, relapse to maladaptive eating habits during dieting is
often provoked by stress.Weadapted a drug relapse-reinstatement
model to study the role of stress in relapse to food seeking
(Nair et al., Prog. Neurobiol., 2009). In our model, the anxiogenic
drug yohimbine, an alpha-2 adrenoceptor antagonist, that causes
stress-like responses in humans and laboratory animals, reliably
reinstates food seeking.Werecently found that yohimbine-induced
reinstatement of food seeking is attenuated by systemic injections
of SCH23390 (a D1-family receptor antagonist) but not clonidine
(an alpha-2 adrenoceptor agonist). Here, we studied the role of
the medial prefrontal cortex (mPFC) in yohimbine-induced reinstatement.
We trained food-restricted rats to lever-press for 35%
high-fat pellets every other day (9–15 3 h sessions). We then extinguished
the food-reinforced operant responding for 10–14 days by
removing the pellets. Subsequently, we tested the effect of systemic
injections of yohimbine (0, 2 mg/kg) on reinstatement of food
seeking. In Exp. 1we found that yohimbine-induced reinstatement
was associated with strong induction of Fos (a marker of neuronal
activity) in the dorsal mPFC and weaker Fos induction in the ventral
mPFC. In Exp. 2 we found that dorsal but not ventral mPFC
injections of the D1-family receptor antagonist SCH23390 (0.5,
1.0g/side) decreased yohimbine-induced reinstatement of food
seeking. Our data indicate a critical role of dorsal mPFC dopamine in
reinstatement food seeking induced by the pharmacological stressor
yohimbine
The effects of stimulants and depressants on cocaine self-administration behavior in the Rhesus monkey
The effects of acute intramuscular pretreatment with several dosages of a variety of centrally acting compounds on intravenous cocaine self-administration behavior were ascertained. Pretreatment with morphine and pentobarbital produced no change in this behavior until dosages (2.0 mg/kg and 15.0 mg/kg respectively) were administered which grossly depressed grooming, exploratory, and locomotor activity behaviors, d -amphetamine (0.5–4.0 mg/kg) and phenmetrazine (2.0–12.0 mg/kg) pretreatment produced a dose-related decrease in cocaine self-administration. Trifluoperazine in dosages of 0.01–0.1 mg/kg increased the frequency of this behavior; whereas, higher dosages (0.2, 0.4 mg/kg) grossly depressed behavior. Imipramine (10–50 mg/kg) produced a dose-related decrease in cocaine self-administration. Potential mechanisms of these drug—behavior and drug—drug interactions are discussed.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46388/1/213_2004_Article_BF00421274.pd
Psychomotor stimulant self administration as a function of dosage per injection in the Rhesus monkey
The relationships between drug dosage per injection and response rate, and drug dosage per injection and total daily drug intake were ascertained in Rhesus monkeys which self-administered cocaine, pipradrol, methylphenidate and phenmetrazine intravenously. The study demonstrated the monkeys would self-administer all of these compounds over a wide range of dosages. Furthermore, the magnitude of reinforcement, i.e., dosage per injection, and the rate of responding in self-administering these compounds were inversely related. However, total daily drug intake was independent of the dosage per injection over a wide range of dosages. The results indicate that either the subjects can compensate for large changes in unit dosage so that daily drug intake remains stable or that a direct effect of these compounds functions in limiting their self-administration.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46379/1/213_2004_Article_BF00401789.pd
Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Molecular Pharmaceutics, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see doi.org/10.1021/acs.molpharmaceut.9b00063.Multiple sclerosis represents the world’s most common cause of neurological disability in young people and is attributed to a loss of immune tolerance toward proteins of the myelin sheath. Typical treatment options for MS patients involve immunomodulatory drugs, which act non-specifically, resulting in global immunosuppression. The study discussed herein aims to demonstrate the efficacy of antigen-specific immunotherapies involving conjugation of disease causing auto-antigen, PLP139–151, and a potent immunosuppressant, dexamethasone. Antigen-drug conjugates (AgDCs) were formed using copper-catalyzed azide-alkyne cycloaddition chemistry with the inclusion of a hydrolyzable linker to maintain activity of released dexamethasone. Subcutaneous administration of this antigen-drug conjugate to SJL mice induced with experimental autoimmune encephalomyelitis protected the mice from symptom onset throughout the 25-day study, demonstrating enhanced efficacy in comparison to dexamethasone treatment. These results highlight the benefits of co-delivery of auto-antigens with immunosuppressant drugs as AgDCs for the treatment of autoimmune diseases.National Institutes of Health Graduate Training Program in Dynamic Aspects of Chemical Biology Grant (T32 GM008545)Howard Rytting pre-doctoral fellowship from the Department of Pharmaceutical Chemistry at the University of KansasNational Institutes of Health Biotechnology Training Grant (NIH0073415)NIH Shared Instrumentation Grant # S10RR024664NSF Major Research Instrumentation Award # 162592
The Making of a Self-Neglect Severity Scale
Research in elder self-neglect has lagged behind that of other forms of mistreatment, despite the fact that self-neglect is the most common allegation reported to Adult Protective Service agencies throughout the US. The lack of a gold-standard to measure self-neglect has hampered efforts to study this phenomenon. Researchers designed the Self-neglect Severity Scale (SSS) based on interviews with Adult Protective Service workers and a national expert panel. The SSS is based on observation and interview and is administered in the home to include an environmental assessment. It was piloted, extensively field tested and then revised. The CREST SSS was developed using survey data and consultation with experts in the field. This instrument utilizes observer ratings, interview responses, and assesses subjects physical and environmental domains. It also assesses functional status as it relates to health and safety issues. After field and pilot testing the SSS was finalized and is currently undergoing reliability and validity testing. The CREST SSS was developed as a state scale to provide a common language for describing cases of self-neglect. It is the first self-neglect severity scale available to researchers. If found to be both reliable and valid it can be used in future intervention studies
HST/WFPC2 and VLA Observations of the Ionized Gas in the Dwarf Starburst Galaxy NGC 4214
We present new H alpha and [O III] 5007 narrow band images of the
starbursting dwarf galaxy NGC 4214, obtained with the WFPC2 onboard HST,
together with VLA observations of the same galaxy. The HST images resolve
features down to physical scales of 2-5 pc, revealing several young (<10 Myr)
star forming complexes of various ionized gas morphologies (compact knots,
complete or fragmentary shells) and sizes (10-200 pc). Our results are
consistent with a uniform set of evolutionary trends: The youngest, smaller,
filled regions that presumably are those just emerging from dense star forming
clouds, tend to be of high excitation and are highly obscured. Evolved, larger
shell-like regions have lower excitation and are less extincted due of the
action of stellar winds and supernovae. In at least one case we find evidence
for induced star formation which has led to a two-stage starburst. Age
estimates based on W(H alpha) measurements do not agree with those inferred
from wind-driven shell models of expanding H II regions. The most likely
explanation for this effect is the existence of a 2 Myr delay in the formation
of superbubbles caused by the pressure exerted by the high density medium in
which massive stars are born. We report the detection of a supernova remnant
embedded in one of the two large H II complexes of NGC 4214. The dust in NGC
4214 is not located in a foreground screen but is physically associated with
the warm ionized gas.Comment: 41 pages, including 9 figures and 7 tables. To appear in the November
issue of the Astronomical Journa
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types
Food- and drug-reinforced responding: Effects of DITA and d -amphetamine
Intravenous pretreatment with DITA (0.1–1.0 mg/kg) decreased the rate of food-reinforced lever pressing in rhesus monkeys. Response rate decreases were dose-dependent but showed the development of tolerance. Self-administration of DITA was initiated and maintained in each of three monkeys when 30 lever presses were required to produce each injection. Maximal response rate during periods of drug availability was maintained by 0.03 mg/kg/injection while higher and lower doses (0.01 and 0.10 mg/kg/injection) maintained lower response rates. Response rate in periods of food availability immediately preceding drug periods was relatively constant across sessions; response rate in periods of food availability immediately following drug periods, however, decreased with increasing amounts of drug self-administered. Replication of initial self-administration doses produced results comparable to original determinations in contrast to the tolerance observed with DITA effects upon food-reinforced responding. DITA was about 3 times less potent than d -amphetamine in maintaining response rates in drug periods and in decreasing the rate of subsequent food-reinforced responding.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46391/1/213_2004_Article_BF00437608.pd
Promising insights into the health related quality of life for children with severe obesity
Background
Childhood obesity is a growing health concern known to adversely affect quality of life in children and adolescents. The Patient Reported Outcomes Measurement Information System (PROMIS) pediatric measures were developed to capture child self-reports across a variety of health conditions experienced by children and adolescents. The purpose of this study is to begin the process of validation of the PROMIS pediatric measures in children and adolescents affected by obesity.
Methods
The pediatric PROMIS instruments were administered to 138 children and adolescents in a cross-sectional study of patient reported outcomes in children aged 8–17 years with age-adjusted body mass index (BMI) greater than the 85th percentile in a design to establish known-group validity. The children completed the depressive symptoms, anxiety, anger, peer relationships, pain interference, fatigue, upper extremity, and mobility PROMIS domains utilizing a computer interface. PROMIS domains and individual items were administered in random order and included a total of 95 items. Patient responses were compared between patients with BMI 85 to < 99th percentile versus ≥ 99th percentile.
Results
136 participants were recruited and had all necessary clinical data for analysis. Of the 136 participants, 5% ended the survey early resulting in missing domain scores at the end of survey administration. In multivariate analysis, patients with BMI ≥ 99th percentile had worse scores for depressive symptoms, anger, fatigue, and mobility (p < 0.05). Parent-reported exercise was associated with better scores for depressive symptoms, anxiety, and fatigue (p < 0.05).
Conclusions
Children and adolescents ranging from overweight to severely obese can complete multiple PROMIS pediatric measures using a computer interface in the outpatient setting. In the 5% with missing domain scores, the missing scores were consistently found in the domains administered last, suggesting the length of the assessment is important. The differences in domain scores found in this study are consistent with previous reports investigating the quality of life in children and adolescents with obesity. We show that the PROMIS instrument represents a feasible and potentially valuable instrument for the future study of the effect of pediatric obesity on quality of life
About Attitudes and Perceptions: Finding the Proper Way to Consider Latent Variables in Discrete Choice Models
- …